These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
701 related items for PubMed ID: 14760889
1. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation. Prösch S, Priemer C, Höflich C, Liebenthaf C, Babel N, Krüger DH, Volk HD. Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889 [Abstract] [Full Text] [Related]
3. Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells. Caposio P, Musso T, Luganini A, Inoue H, Gariglio M, Landolfo S, Gribaudo G. Antiviral Res; 2007 Mar; 73(3):175-84. PubMed ID: 17070604 [Abstract] [Full Text] [Related]
4. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors. Sakai T, Kambe F, Mitsuyama H, Ishiguro N, Kurokouchi K, Takigawa M, Iwata H, Seo H. J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703 [Abstract] [Full Text] [Related]
5. Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB. La Frazia S, Amici C, Santoro MG. Antivir Ther; 2006 Jul; 11(8):995-1004. PubMed ID: 17302369 [Abstract] [Full Text] [Related]
6. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Ahn JH, Hayward GS. Virology; 2000 Aug 15; 274(1):39-55. PubMed ID: 10936087 [Abstract] [Full Text] [Related]
8. Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. Fortunato EA, Sanchez V, Yen JY, Spector DH. J Virol; 2002 Jun 15; 76(11):5369-79. PubMed ID: 11991965 [Abstract] [Full Text] [Related]
15. Proteasome inhibitor differentially regulates expression of the major immediate early genes of human cytomegalovirus in human central nervous system-derived cell lines. Sadanari H, Tanaka J, Li Z, Yamada R, Matsubara K, Murayama T. Virus Res; 2009 Jun 01; 142(1-2):68-77. PubMed ID: 19201384 [Abstract] [Full Text] [Related]
16. Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signal-regulating kinase-dependent extracellular signal-related kinase and c-Jun N-terminal kinase activation. Wu HM, Wen HC, Lin WW. Am J Respir Cell Mol Biol; 2002 Aug 01; 27(2):234-43. PubMed ID: 12151316 [Abstract] [Full Text] [Related]
17. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor. Wang XC, Jobin C, Allen JB, Roberts WL, Jaffe GJ. Invest Ophthalmol Vis Sci; 1999 Feb 01; 40(2):477-86. PubMed ID: 9950608 [Abstract] [Full Text] [Related]
18. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity. Gribaudo G, Ravaglia S, Gaboli M, Gariglio M, Cavallo R, Landolfo S. Virology; 1995 Aug 01; 211(1):251-60. PubMed ID: 7645218 [Abstract] [Full Text] [Related]